Physician profile
Gloria Bernard
NPI 1548368236
$1,292.11
in general payments reported to CMS, 2019-2025
11 companies · $750 in 2025
The $750 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $109 · 2023: $245 · 2024: $71.38 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,066.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stemline Therapeutics INC. | $244.53 | 2023 | Orserdu |
| Legend Biotech USA INC. | $128.60 | 2025 | Carvykti |
| Exelixis INC. | $124.98 | 2025 | Cabometyx |
| Regeneron Healthcare Solutions, INC. | $124.98 | 2025 | Libtayo |
| Ipsen Biopharmaceuticals, INC | $116.91 | 2021 | |
| Janssen Biotech, INC. | $115.43 | 2025 | Rybrevant, Carvykti |
| Glaxosmithkline, LLC. | $109.01 | 2022 | |
| Syndax Pharmaceuticals, INC. | $92.59 | 2025 | Revuforj |
| Geron Corporation | $83.07 | 2025 | Rytelo |
| Immunocore Limited | $80.63 | 2025 | Kimmtrak |
| Eisai INC. | $71.38 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gloria Bernard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.